NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value, $0.001 per share
Symbol
NMTC on Nasdaq
Shares outstanding
50,013,453
Price per share
$0.76
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
14,406,380
Total reported value
$12,801,427
% of total 13F portfolios
0%
Share change
+873,880
Value change
+$798,232
Number of holders
34
Price from insider filings
$0.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MERCHANT ADVENTURE FUND, L.P. 14% $2,478,000 4,200,000 MERCHANT ADVENTURE FUND, L.P. 31 Dec 2024
Bleichroeder LP 8% $2,800,000 4,000,000 Bleichroeder LP 30 Jun 2025
Sio Capital Management, LLC 4.7% -34% $2,098,132 -$1,033,699 2,360,635 -33% Sio Capital Management, LLC 30 Sep 2025
AWM Investment Company, Inc. 4.8% $1,388,959 2,354,167 AWM Investment Company, Inc. 31 Mar 2025
MANCHESTER MANAGEMENT CO LLC 4.9% $934,166 1,583,332 JAMES E. BESSER 31 Dec 2024
LYTTON LAURENCE W 2.6% $764,220 1,295,288 LYTTON LAURENCE W 31 Mar 2025
Nantahala Capital Management, LLC 2.6% $471,270 798,762 Nantahala Capital Management, LLC 30 Sep 2024

As of 30 Sep 2025, 34 institutional investors reported holding 14,406,380 shares of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC). This represents 29% of the company’s total 50,013,453 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bleichroeder LP 8% 4,000,000 0% 0.69% $3,554,400
Sio Capital Management, LLC 4.7% 2,360,635 -33% 0.53% $2,097,660
BARD ASSOCIATES INC 3.7% 1,851,000 -0.19% 0.44% $1,644,799
VANGUARD GROUP INC 3.2% 1,578,237 +31% 0% $1,403,053
PERKINS CAPITAL MANAGEMENT INC 2.9% 1,468,000 -2.1% 1.1% $1,304,465
AWM Investment Company, Inc. 1.8% 916,667 0.08% $814,550
RENAISSANCE TECHNOLOGIES LLC 1.4% 692,600 +48% 0% $615,444
GEODE CAPITAL MANAGEMENT, LLC 0.99% 496,834 +42% 0% $441,552
CITADEL ADVISORS LLC 0.41% 206,277 +195% 0% $183,298
Cambridge Investment Research Advisors, Inc. 0.24% 121,000 +49% 0% $108,000
NORTHERN TRUST CORP 0.22% 112,123 +129% 0% $99,632
JANE STREET GROUP, LLC 0.22% 108,297 0% $96,233
Virtu Financial LLC 0.2% 99,200 0% $88,000
STATE STREET CORP 0.12% 59,499 0% 0% $52,871
BLAIR WILLIAM & CO/IL 0.11% 55,556 0% 0% $49,367
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.11% 53,179 0% $47,255
MAI Capital Management 0.1% 50,000 0% 0% $44,430
J.W. COLE ADVISORS, INC. 0.07% 37,120 0% 0% $32,985
Focus Financial Network, Inc. 0.07% 34,722 0% $30,854
XTX Topco Ltd 0.04% 20,291 -73% 0% $18,031
Princeton Global Asset Management LLC 0.03% 16,833 0% 0% $14,958
SIMPLEX TRADING, LLC 0.03% 13,447 0% $11,000
MORGAN STANLEY 0.02% 12,488 -7.1% 0% $11,097
TWO SIGMA SECURITIES, LLC 0.02% 12,357 0% $10,980
LPL Financial LLC 0.02% 10,934 0% $9,716

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 51,555 $39,078 $0.76 2
2025 Q3 14,406,380 $12,801,427 +$798,232 $0.89 34
2025 Q2 13,532,500 $9,178,137 +$7,852,763 $0.68 30
2025 Q1 1,929,327 $1,640,294 +$267,014 $0.85 18
2024 Q4 1,618,518 $1,336,454 -$822,631 $0.83 20
2024 Q3 2,423,467 $2,399,034 -$268,422 $0.99 21
2024 Q2 2,735,360 $2,187,702 -$97,024 $0.80 18
2024 Q1 2,846,820 $3,416,201 -$33,927 $1.20 18
2023 Q4 2,862,898 $4,523,339 +$578,694 $1.58 20
2023 Q3 2,618,184 $2,331,807 +$1,492,764 $0.89 18
2023 Q2 938,623 $1,126,777 -$44,391 $1.20 13
2023 Q1 962,913 $1,549,540 +$453,337 $1.61 14
2022 Q4 722,249 $866,359 +$155,582 $1.20 18
2022 Q3 409,378 $686,000 +$3,717 $1.69 9
2022 Q2 479,839 $394,000 -$269,817 $0.82 8
2022 Q1 707,048 $777,000 -$2,285,922 $1.10 8
2021 Q4 1,946,125 $3,774,000 +$3,070,716 $1.94 12
2021 Q3 250,733 $989,000 -$398,000 $3.94 6
2021 Q2 411,124 $1,522,205 +$1,521,000 $6.63 3